R

$RPRX

2 articles found
1 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Vera Therapeutics Bolsters Board with Royalty Pharma Executive Ahead of Key Drug Launch

Vera Therapeutics appoints Christopher Hite, Royalty Pharma EVP, to board as the biotech prepares for atacicept launch in IgA nephropathy treatment.
RPRXVERAbiopharmaceuticalIgA nephropathy
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Royalty Pharma Bets Big on Asia Boom With New Regional Leadership

Royalty Pharma appoints Morgan Stanley veteran Kenneth Sun as SVP to lead Asia expansion, targeting region's surging biotech market and $130B medicine licensing opportunity.
MSMSpAMSpEMSpFMSpI+6Asia expansionnon-dilutive capital